A randomized, investigator- masked clinical trial comparing the efficacy and safety of gatifloxacin 0.3% administered BID versus QID for the treatment BID versus QID for the treatment of acute bacterial conjunctivitis of acute bacterial conjunctivit (Q46422799)
Jump to navigation
Jump to search
scientific article published in March 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, investigator- masked clinical trial comparing the efficacy and safety of gatifloxacin 0.3% administered BID versus QID for the treatment BID versus QID for the treatment of acute bacterial conjunctivitis of acute bacterial conjunctivit |
scientific article published in March 2005 |
Statements
1 reference
A randomized, investigator- masked clinical trial comparing the efficacy and safety of gatifloxacin 0.3% administered BID versus QID for the treatment BID versus QID for the treatment of acute bacterial conjunctivitis of acute bacterial conjunctivit (English)
1 reference
Scott M Whitcup
1 reference
Richard W Yee
1 reference
Michael Tepedino
1 reference
Paula Bernstein
1 reference
Harold Jensen
1 reference
Rhett Schiffman
1 reference
Gatifloxacin BID/QID Study Group
1 reference
1 March 2005
1 reference
21
1 reference
3
1 reference
425-431
1 reference